Does intravenous ondansetron affect gastric emptying of a solid meal, gastric electrical activity or blood hormone levels in healthy volunteers?

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 1, 2002, Pages 119-127

  Netzer, P ^a   Gaia, C ^a   Lourens, S T ^a   Reber, P ^a   Wildi, S ^a   Noelpp, U ^a   Ritter, E P ^a   Ledermann, H ^a   Luscher D ^a   Varga, L ^a   Kinser, J A ^a   Buchler M W ^a   Scheurer, U ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; GALANIN; GASTRIC INHIBITORY POLYPEPTIDE; GASTRIN; HORMONE; ICI 205 930; MOTILIN; ONDANSETRON; PANCREAS POLYPEPTIDE; PLACEBO; SEROTONIN 3 ANTAGONIST; SUBSTANCE P; TROPISETRON; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; ELECTROGASTROGRAPHY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; MYOELECTRICITY; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCINTIGRAPHY; SEX DIFFERENCE; SINGLE BLIND PROCEDURE; SOLID; STOMACH EMPTYING; TREATMENT OUTCOME; VOLUNTEER;

ADULT; CROSS-OVER STUDIES; EATING; ELECTROPHYSIOLOGY; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL HORMONES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; ONDANSETRON; POSTPRANDIAL PERIOD; SEROTONIN ANTAGONISTS; STOMACH;

EID: 0036164194     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01152.x     Document Type: Article

References (63)

1. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting
2. Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation
3. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy
4. Tropisetron: An update of its use in the prevention of chemotherapy-induced nausea and vomiting
5. Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications
6. The importance of 5-hydroxytryptamine receptors in the gut
7. Review article: Roles played by 5-hydroxytryptamine in the physiology of the bowel
8. 5-Hydroxytryptamine receptor antagonism by metoclopramicle and ICS 205-930 in the guinea-pig leads to enhancement of contractions of stomach muscle strips induced by electrical field stimulation and facilitation of gastric emptying in-vivo
9. The effect of GR38032F, novel 5-HT3-receptor antagonist, on gastric emptying in the guinea-pig
10. Effect of serotonin (5-HT)3-receptor antagonists YM060. YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents
11. Effect of Y-25130, a selective 5-hydroxytryptamine3 receptor antagonist, on gastric emptying in mice
12. 5-Hydroxytryptamine3 receptor and regulation of gastric emptying in rats
13. Effect of ICS 205-125, a potential prokinetic agent, on upper gastrointestinal (GI) motility in normal subjects
14. Effect of ICS 205-930 (a specific 5-HT3 receptor antagonist) on gastric emptying of a solid meal in normal subjects
15. Lack of systematic effects of the 5-hydroxytryptamine 3 receptor antagonist ICS 205-930 on gastric emptying and antral motor activity in patients with primary anorexia nervosa
16. Gastric emptying and subjective symptoms of nausea: Lack of effects of a 5-hydroxytryptamine-3 antagonist ondansetron on gastric emptying in patients with gastric stasis syndrome (published erratum appears in Digestion 1990; 47(4): 235)
17. Effect of selective 5HT3 antagonist (GR 38032F) on small intestinal transit and release of gastrointestinal peptides
18. Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist
19. The effect of metoclopramide, ondansetron, and granisetron on liquid gastric emptying in normal subjects
20. Effects of the 5-HT3 receptor antagonist ICS 205-930 on fat-delayed gastric emptying and antral motor activity
21. Effect of gastric acid suppressants on human gastric motility
22. Circadian variation in gastric emptying of meals in humans
23. Considerations for accurately measuring gastric emptying
24. Comparison of left anterior oblique, anterior and geometric mean methods for determining gastric emptying times
25. Anterior posterior left anterior oblique, geometric mean views in gastric emptying studies using a glucose solution
26. Electrogastrography in healthy subjects. Evaluation of normal values, influence of age and gender
27. Influence of age, gender, and menstrual cycle on the normal electrogastrogram
28. Efficiency and efficacy of the electrogastrogram
29. Effect of meal temperature on the frequency of gastric myoelectrical activity
30. Pitfalls in the analysis of electrogastrographic recordings
31. Effects of prolonged administration of metiamide on serum gastrin, gastrin content of the antrum and gastric corpus, and G-cell population in the rat
32. The release of pancreatic polypeptide by CCK-octapeptide and some analogues in the dog
33. 4 receptor agonist in the gut
34. The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis
35. Gastroprokinetic properties of the benzimidazolone derivative BIMU 1, an agonist at 5-hydroxytryptamine4 and antagonist at 5-hydroxytryptamine3 receptors
36. Inter-species variants of the 5-HT3 receptor
37. Effect of a selective 5-HT3 receptor agonist on gastric motility in fasted and fed dogs
38. Blockade of 5-HT-mediated enteric slow EPSPs by BRL 24924: Gastrokinetic effects
39. The effect of ondansetron on gastric emptying in the conscious rat
40. Pharmacological properties of quinoxaline derivatives as a new class of 5-HT3 receptor antagonists
41. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs
42. 5-HT3 receptor antagonists: Differences and similarities
43. The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons
44. Benzimidazolones and renzapride facilitate acetylcholine release from guinea-pig myenteric plexus via 5-HT4 receptors
45. Analysis of serotonergic mechanisms underlying benzamide-induced gastroprokinesis
46. Participation of a cholinergic mechanism in 5-hydroxytryptamine (5-HT)3 and 5-HT4 receptor-mediated stimulation of gastric emptying in rats
47. 3 antagonism
48. Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome
49. Oesophageal and gastric motility disorders in patients categorised as having primary anorexia nervosa
50. Ondansetron reduces nausea induced by gastroduodenal stimulation without changing gastric motility
51. GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man
52. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride
53. Gender-related differences in gastric emptying
54. Electrogastrography and gastric emptying scintigraphy are complementary for assessment of dyspepsia
55. The effect of cisapride on dyspepsia symptoms and the electrogastrogram in patients with non-ulcer dyspepsia
56. Cytotoxic chemotherapy has minimal direct effect on gastric myoelectric activity in children with 5HT(3) antagonist prophylaxis
57. Differential symptomatic and electrogastrographic effects of distal and proximal human gastric distension
58. Gut hormone release induced by food ingestion
59. Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: Studies with the CCK antagonist loxiglumide
60. 5-Hydroxytryptamine-3 receptors are involved in the initiation of gastric phase-3 motor activity in humans